Home
Solution
Company
Blog
News
Contact

Sartar was awarded a U.S. patent

16.10.2017 News

Sartar was awarded a U.S. patent for use of anagrelide in cancer therapy.

growth
innovation
life science
research
startup
technology

Revolutionizing soft tissue sarcoma therapy

Sartar Therapeutics Ltd.
Terkko Health Hub
Haartmaninkatu 4, building 14
FI-00290 Helsinki
Finland

firstname.lastname@sartartherapeutics.com

VAT(id): FI27546548

© All Rights Reserved by Sartar Therapeutics Ltd.